Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) is partnering with the BC Cancer Foundation to showcase Verisante Aura, a device for the rapid detection of skin cancer.
Aura
“We are very appreciative of the BC Cancer Foundation’s support for Verisante and for Aura, and also for the foundation’s dedication to raising funds that support innovative research directed at achieving the highest standard of care for every patient facing cancer in B.C.,” Verisante president and CEO, Thomas Braun, said in a statement.
Verisante has placed an Aura device at the foundation’s office in Vancouver for display and educational purposes.
Douglas Nelson, president & CEO of the BC Cancer Foundation, said Aura is one of those “made in BC” inventions coming out of the leading edge technology and research efforts of the BC Cancer Agency. “Our foundation is pleased to have the opportunity to demonstrate and promote this exciting technology.”
